Clinical characteristics of tumors derived from colorectal cancer patients who harbor the Tumor Necrosis Factor α-1031T/T and NOD2 3020insC polymorphism

2009 ◽  
Vol 33 (2) ◽  
pp. 161-163 ◽  
Author(s):  
Józef Kładny ◽  
Janina Suchy ◽  
Ewa Kłujszo-Grabowska ◽  
Tomasz Kacperski ◽  
Rodney J. Scott ◽  
...  
2019 ◽  
Vol 39 (1) ◽  
Author(s):  
Xue Huang ◽  
Shanyu Qin ◽  
Yongru Liu ◽  
Lin Tao ◽  
Haixing Jiang

Abstract Background: Recently, the roles of tumor necrosis factor-α (TNF-α) polymorphisms in colorectal cancer (CRC) were analyzed by some pilot studies, with inconsistent results. Therefore, we performed the present study to better assess the relationship between TNF-α polymorphisms and the risk of CRC. Methods: Eligible studies were searched in PubMed, Medline, Embase and CNKI. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess correlations between TNF-α polymorphisms and CRC. Results: A total of 22 studies were included for analyses. A significant association with the risk of CRC was detected for TNF-α -308 G/A (recessive model: P = 0.004, OR = 1.42, 95%CI 1.12–1.79) polymorphism in overall analyses. Further subgroup analyses based on ethnicity of participants revealed that TNF-α -238 G/A was significantly correlated with the risk of CRC in Caucasians (dominant model: P = 0.01, OR = 0.47, 95%CI 0.26–0.86; overdominant model: P = 0.01, OR = 2.27, 95%CI 1.20–4.30; allele model: P = 0.02, OR = 0.51, 95%CI 0.29–0.90), while -308 G/A polymorphism was significantly correlated with the risk of CRC in Asians (recessive model: P = 0.001, OR = 2.23, 95%CI 1.38–3.63). Conclusions: Our findings indicated that TNF-α -238 G/A polymorphism may serve as a potential biological marker for CRC in Caucasians, and TNF-α -308 G/A polymorphism may serve as a potential biological marker for CRC in Asians.


Nutrition ◽  
2007 ◽  
Vol 23 (7-8) ◽  
pp. 529-532 ◽  
Author(s):  
Daniel Antonio de Luis ◽  
Manue Gonzalez Sagrado ◽  
Luis Angel Vallejo ◽  
Luis María Gil Carcedo ◽  
Olatz Izaola ◽  
...  

2011 ◽  
Vol 26 (3) ◽  
pp. 275-282 ◽  
Author(s):  
Sang Mi Kwak ◽  
Youn Seon Choi ◽  
Ho Min Yoon ◽  
Dae Gyun Kim ◽  
Seung Hun Song ◽  
...  

2000 ◽  
Vol 24 (6) ◽  
pp. 329-336 ◽  
Author(s):  
Marian A. E. van Bokhorst-de van der Schueren ◽  
B. Mary E. von Blomberg-van der Flier ◽  
Dirk J. Kuik ◽  
Petra E. T. Scholten ◽  
Michiel P. C. Siroen ◽  
...  

2017 ◽  
Vol 45 (3) ◽  
pp. 1024-1035 ◽  
Author(s):  
Laura Gonzalez-Lopez ◽  
Nicte S. Fajardo-Robledo ◽  
A. Miriam Saldaña-Cruz ◽  
Inocente V. Moreno-Sandoval ◽  
David Bonilla-Lara ◽  
...  

Objective To identify correlations of the serum leptin, adiponectin, interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) concentrations with the clinical characteristics, presence of spinal syndesmophytes, and body composition in patients with ankylosing spondylitis (AS). Methods Forty-eight patients with AS were compared with 41 sex- and age-matched controls. Assessment included clinical characteristics and the presence of spinal syndesmophytes. The serum leptin, adiponectin, TNF-α, and IL-6 concentrations were determined. Body composition was evaluated using dual-energy X-ray absorptiometry. Results Patients with AS and controls had similar fat mass and lean mass. Patients with AS had higher serum TNF-α and leptin concentrations than controls (52.3 vs. 1.5 pg/mL and 17.2 vs. 9.0 µg/mL, respectively). The IL-6 and adiponectin concentrations were not significantly different between the two groups. Patients with syndesmophytes had higher leptin concentrations than those without syndesmophytes (22.1 vs. 10.9 µg/mL); this difference remained after adjustment for the body mass index. Conclusion Elevated leptin concentrations are associated with spinal radiographic damage in patients with AS and can serve as a biomarker. Future studies should evaluate whether leptin might be a potential target for treatments to avoid structural damage.


Sign in / Sign up

Export Citation Format

Share Document